Advertisement
Research ArticleINFLAMMATION AND IMMUNOPHARMACOLOGY

Anti-Inflammatory Effects of ABT-702, a Novel Non-Nucleoside Adenosine Kinase Inhibitor, in Rat Adjuvant Arthritis

David L. Boyle, Elizabeth A. Kowaluk, Michael F. Jarvis, Chih-Hung Lee, Shripad S. Bhagwat, Michael Williams and Gary S. Firestein
Journal of Pharmacology and Experimental Therapeutics February 2001, 296 (2) 495-500;
Submit a Response to This Article
Compose eLetter

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.
Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools
Research ArticleINFLAMMATION AND IMMUNOPHARMACOLOGY

Anti-Inflammatory Effects of ABT-702, a Novel Non-Nucleoside Adenosine Kinase Inhibitor, in Rat Adjuvant Arthritis

David L. Boyle, Elizabeth A. Kowaluk, Michael F. Jarvis, Chih-Hung Lee, Shripad S. Bhagwat, Michael Williams and Gary S. Firestein
Journal of Pharmacology and Experimental Therapeutics February 1, 2001, 296 (2) 495-500;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Jump to section

Advertisement